Tretinoin, the first successful differentiating agent, approed by FDA for use in acute promyelocytic leukemia.
FDA批准首个有效的促分化药物-维A酸治疗急性早幼粒细胞白血病.
互联网
Tretinoin, the first successful differentiating agent , approved by FDA for use in acute promyelocytic leukemia.
fda批准首个有效的促分化药物-维A酸治疗急性早幼粒细胞白血病.
互联网
Also combination drug has a lower concentration of tretinoin than 0.1 % tretinoin microsphere gel, he noted.
而且,这种复方药比0.1%维甲酸微凝胶浓度低, 他指出.
互联网